Background: Insect sting reactions are frequently reported, but population studies documenting the frequency and the relation to IgE-sensitization and serum tryptase are scarce. Methods: Questionnaire data and results from measurements of specific IgE against venom, major allergens and cross-reacting carbohydrate determinants (CCDs) were collected from 2,090 adult participants in a cross-sectional survey. Results: 13% of the population reported symptoms of sting reactions and about half were systemic in nature. In all, 15% were sensitized to venom but only 31% of these had reacted to stings and only 38% of those with reactions had IgE to venom. In addition, 12% with IgE to venom were double-sensitized (DS), i.e. to both bee and wasp venom. Among DS IgE to major venom allergens, rApi m 1, rVes v 1 and rVes v 5 were negative and of no help in 31%, but 59% could be identified as likely sensitized to bee or wasp. IgE to CCDs occurred in only 0.7%, but 80% of these were DS. Finally, 36% with IgE to CCDs had had symptoms, mostly local. Serum tryptase was not associated with a history of sting reactions. Conclusions: In a temperate climate, self-reported insect sting reactions and sensitization to venom are frequent, but in most cases, these are not seen in the same individual. In DS individuals, measurements of IgE to major allergens can be helpful in some but not all cases and additional analyses are needed. IgE to CCDs may have some clinical relevance.

1.
Bilò BM, Bonifazi F: Epidemiology of insect-venom anaphylaxis. Curr Opin Allergy Clin Immunol 2008;8:330-337.
2.
Bokanovic D, Aberer W, Griesbacher A, Sturm GJ: Prevalence of Hymenoptera venom allergy and poor adherence to immunotherapy in Austria. Allergy 2011;66:1395-1396.
3.
Biló BM, Rueff F, Mosbech H, Bonifazi F, Oude-Elberink JNG, Birnbaum J, et al: Diagnosis of Hymenoptera venom allergy. Allergy 2005;60:1339-1349.
4.
Kucharewicz I, Bodzenta-Lukaszyk A, Szymanski W, Mroczko B, Szmitkowski M: Basal serum tryptase level correlates with severity of hymenoptera sting and age. J Investig Allergol Clin Immunol 2007;17:65-69.
5.
Ruëff F, Przybilla B, Biló MB, Müller U, Scheipl F, Aberer W, et al: Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase - a study of the European Academy of Allergology and Clinical Immunology Interest Group on insect venom hypersensitivity. J Allergy Clin Immunol 2009;124:1047-1054.
6.
Thuesen BH, Cerqueira C, Aadahl M, Ebstrup JF, Toft U, Thyssen JP, et al: Cohort profile: the Health2006 cohort, Research Centre for Prevention and Health. Int J Epidemiol 2014;43:568-575.
7.
Gonzalez-Quintela A, Dam Laursen AS, Vidal C, Skaaby T, Gude F, Linneberg A: IgE antibodies to alpha-gal in the general adult population: relationship with tick bites, atopy, and cat ownership. Clin Exp Allergy 2014;44:1061-1068.
8.
Bonadonna P, Perbellini O, Passalacqua G, Caruso B, Colarossi S, Dal Fior D, et al: Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol 2009;123:680-686.
9.
Von Moos S, Graf N, Johansen P, Müllner G, Kündig TM, Senti G: Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy. Int Arch Allergy Immunol 2013;160:86-92.
10.
Graif Y, Romano-Zelekha O, Livne I, Green MS, Shohat T: Allergic reactions to insect stings: results from a national survey of 10,000 junior high school children in Israel. J Allergy Clin Immunol 2006;117:1435-1439.
11.
Fernandez J, Blanca M, Soriano V, Sanchez J, Juarez C: Epidemiological study of the prevalence of allergic reactions to Hymenoptera in a rural population in the Mediterranean area. Clin Exp Allergy 1999;29:1069-1074.
12.
Navarro LA, Peláez A, de la Torre F, Burillo JMT, Megías J, Martínez I: Epidemiological factors on Hymenoptera venom allergy in a Spanish adult population. J Investig Allergol Clin Immunol 2004;14:134-141.
13.
Mosbech H: Insect allergy. A comparative study including case histories and immunological parameters. Allergy 1984;39:543-549.
14.
Golden DBK, Marsh DG, Freidhoff LR, Kwitterovich KA, Addison B, Kagey-Sobotka A, et al: Natural history of Hymenoptera venom sensitivity in adults. J Allergy Clin Immunol 1997;100:760-766.
15.
Linneberg A, Nielsen NH, Madsen F, Frølund L, Dirksen A, Jørgensen T: Increasing prevalence of specific IgE to aeroallergens in an adult population: two cross-sectional surveys 8 years apart: the Copenhagen Allergy Study. J Allergy Clin Immunol 2000;106:247-252.
16.
Sturm GJ, Kranzelbinder B, Schuster C, Sturm EM, Bokanovic D, Vollmann J, et al: Sensitization to Hymenoptera venoms is common, but systemic sting reactions are rare. J Allergy Clin Immunol 2014;133:1635-1643.
17.
Golden DBK: Large local reactions to insect stings. J Allergy Clin Immunol Pract 2015;3:331-334.
18.
Baker TW, Forester JP, Johnson ML, Stolfi A, Stahl MC: The HIT study: Hymenoptera identification test - how accurate are people at identifying stinging insects? Ann Allergy Asthma Immunol 2014;113:267-270.
19.
Mittermann I, Zidarn M, Silar M, Markovic-Housley Z, Aberer W, Korosec P, et al: Recombinant allergen-based IgE testing to distinguish bee and wasp allergy. J Allergy Clin Immunol 2010;125:1300-1307.
20.
Müller UR, Johansen N, Petersen AB, Fromberg-Nielsen J, Haeberli G: Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m 1 and Ves v 5. Allergy 2009;64:543-548.
21.
Müller U, Schmid-Grendelmeier P, Hausmann O, Helbling A: IgE to recombinant allergens Api m 1, Ves v 1, and Ves v 5 distinguish double sensitization from cross-reaction in venom allergy. Allergy 2012;67:1069-1073.
22.
Seismann H, Blank S, Cifuentes L, Braren I, Bredehorst R, Grunwald T, et al: Recombinant phospholipase A1 (Ves v 1) from yellow jacket venom for improved diagnosis of Hymenoptera venom hypersensitivity. Clin Mol Allergy 2010;8:7.
23.
Korošec P, Valenta R, Mittermann I, Čelesnik N, Eržen R, Zidarn M, et al: Low sensitivity of commercially available rApi m 1 for diagnosis of honeybee venom allergy. J Allergy Clin Immunol 2011;128:671-673.
24.
Sturm GJ, Hemmer W, Hawranek T, Lang R, Ollert M, Spillner E, et al: Detection of IgE to recombinant Api m 1 and rVes v 5 is valuable but not sufficient to distinguish bee from wasp venom allergy. J Allergy Clin Immunol 2011;128:247-248.
25.
Sturm GJ, Biló MB, Bonadonna P, Hemmer W, Caruso B, Bokanovic D, et al: Ves v 5 can establish the diagnosis in patients without detectable specific IgE to wasp venom and a possible north-south difference in Api m 1 sensitization in Europe. J Allergy Clin Immunol 2012;130:817.
26.
Kochuyt A-M, Van Hoeyveld EM, Stevens EAM: Prevalence and clinical relevance of specific immunoglobulin E to pollen caused by sting-induced specific immunoglobulin E to cross-reacting carbohydrate determinants in Hymenoptera venoms. Clin Exp Allergy 2005;35:441-447.
27.
Hofmann SC, Pfender N, Weckesser S, Huss-Marp J, Jakob T: Added value of IgE detection to rApi m 1 and rVes v 5 in patients with Hymenoptera venom allergy. J Allergy Clin Immunol 2011;127:265-267.
28.
Eberlein B, Krischan L, Darsow U, Ollert M, Ring J: Double positivity to bee and wasp venom: improved diagnostic procedure by recombinant allergen-based IgE testing and basophil activation test including data about cross-reactive carbohydrate determinants. J Allergy Clin Immunol 2012;130:155-161.
29.
Fenger RV, Linneberg A, Vidal C, Vizcaino L, Husemoen LL, Aadahl M, et al: Determinants of serum tryptase in a general population: the relationship of serum tryptase to obesity and asthma. Int Arch Allergy Immunol 2012;157:151-158.
30.
Alvarez-Twose I, Zanotti R, González-de-Olano D, Bonadonna P, Vega A, Matito A, et al.: Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM. J Allergy Clin Immunol 2014;133:520-528.
31.
Sturm GJ, Jin C, Kranzelbinder B, Hemmer W, Sturm EM, Griesbacher A, et al: Inconsistent results of diagnostic tools hamper the differentiation between bee and vespid venom allergy. PLoS One 2011;6:1-8.
32.
Hoffman DR: Structural biology of allergens from stinging and biting insects. Curr Opin Allergy Clin Immunol 2008;8:338-342.
33.
Köhler J, Blank S, Müller S, Bantleon F, Frick M, Huss-Marp J, et al: Component resolution reveals additional major allergens in patients with honeybee venom allergy. J Allergy Clin Immunol 2014;133:1383-1389.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.